RE:RE:Keep in mindPDC is a type of PDT, or photodynamic therapy. Many different researchers, and companies, are developing PDT treatments.
And just because mice are a (relatively) close genetic cousin of ours, that by no means is even a very high correlation of the rate of success you would expect with humans.
Mice take the blame for one of the most uncomfortable truths in translational research. Even after animal studies suggest that a treatment will be safe and effective, more than 80% of potential therapeutics fail when tested in people. Animal models of disease are frequently condemned as poor predictors of whether an experimental drug can become an effective treatment. Often, though, the real reason is that the preclinical experiments were not rigorously designed.
https://www.nature.com/news/preclinical-research-make-mouse-studies-work-1.14913
And my post is not to discount the stock - just to highlight where caution for investors is prudent.